Kolon TissueGene, Inc. announced that it will receive $34,999,709 in funding on May 23, 2024. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Kolon TissueGene, Inc. announced that it will receive $34,999,709 in funding on May 23, 2024. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.